Attendees interested in learning more about CoSara products, including the TB and HPV tests on the Company's upcoming Co-Dx PCR platform, are encouraged to stop by at VIROCON 2025. CoSara will be ...

An investigation into cellular components in bacteria has unexpectedly uncovered a feature with relevance across many life ...

Scientists from Turkey have designed a next-generation implantable biosensor using genetically engineered E. coli for ...

A groundbreaking study introduces new noninvasive screening tools that have the potential to greatly enhance patient comfort ...

The assay detects aggressive prostate tumors in men on active surveillance for low-risk cancer, potentially helping them ...

The United States DNA polymerase market is projected to reach USD 246.9 million by 2035, supported by rising investments in ...

At the meeting, researchers shared real-world data showing ctDNA positivity at the end of treatment was prognostic across lymphoma subtypes and better than PET scans.

Seegene, Inc., a global leader in molecular diagnostics (MDx), announced today the establishment of a new subsidiary in ...

A newly cleared point-of-care test will enable rapid identification of whooping cough, according to a press release from ...

Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample ...

Core to Seegene Mexico are the Allplex and Anyplex HPV 28 Detection assays – real-time multiplexing PCR tests that identify ...

Researchers develop a molecular testing-based fast-throughput method for the rapid and early detection of Salmonella ...